Xcout Intel
Connect Biopharmaceuticals
Connect Biopharmaceuticals is a biopharmaceutical company headquartered in Taicang, China, founded in 2012 to develop novel treatments.
Subscribe to see Connect Biopharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Connect Biopharmaceuticals at a glance
Connect Biopharmaceuticals is a healthcare company headquartered in China. It has raised at least $190M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $115M in August 2020. Xcout tracks 6 named people at Connect Biopharmaceuticals, including Barry Quart (Chief Executive Officer AND DIRECTOR).
Connect Biopharmaceuticals leadership
- Barry QuartChief Executive Officer AND DIRECTOR
- Kleanthis G. XanthopoulosChairman, president and Chief Executive Officer, Senvera therapeutics, inc. and Chairman, Stork Capital Life Sciences
- James Z. HuangFounding Partner of Panacea Venture
- James A SchoeneckBoard Director
- Jean LiuBoard Director
- Karen J WilsonBoard Director
Connect Biopharmaceuticals funding rounds
At least $190M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $115M | 6 named | |
| Series B | $55M | 8 named | |
| Series A | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Connect Biopharmaceuticals competitors
A few of Connect Biopharmaceuticals's closest competitors — see the full list of competitors and alternatives →
Alpha BioPharma is a next-generation pharmaceutical and biotechnology company focused on drug development and research. The company establishes strategic partnerships with leading international pharmaceutical organizations and R&D institutes. Its headquarters is located in Shanghai, China.
CureGenetics is a biotechnology company headquartered in Suzhou, China, focused on the development of gene and cutting-edge medical therapies.
VelaVigo is a leading biotech company specializing in drug discovery and development. The company maintains its global R&D headquarters in Shanghai, China, alongside clinical and operational footprints in Boston, United States.
Ark Biosciences is a biopharmaceutical company headquartered in Shanghai, China, with operations focusing on clinical development and healthcare solutions.
Get Connect Biopharmaceuticals's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Connect Biopharmaceuticals in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access